| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), ENZN's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2023 | Read Randolph C | Director | Buy | 99,550 | $0.14 | $13,909.05 | +99.1% | |
| Aug 13, 2021 | Couchman Jonathan | 10% Owner | Sell | 107,500 | $0.39 | $41,903.50 | -5.0% | |
| Nov 18, 2020 | Read Randolph C | Director | Buy | 100,450 | $0.15 | $15,498.00 | New | |
| Nov 13, 2020 | Bleznick Jordan | Director | Buy | 100,000 | $0.15 | $15,380.00 | New | |
| Aug 25, 2020 | Couchman Jonathan | 10% Owner | Sell | 77,100 | $0.19 | $14,337.64 | -4.6% | |
| Aug 5, 2020 | Couchman Jonathan | 10% Owner | Buy | 506,292 | $0.20 | $101,258.40 | +31.8% | |
| Mar 26, 2020 | Couchman Jonathan | 10% Owner | Buy | 652,723 | $0.14 | $91,282.68 | -3,354% | |
| Feb 11, 2019 | Couchman Jonathan | 10% Owner | Buy | 51,000 | $0.25 | $12,750.00 | +3.3% | |
| Jan 7, 2019 | Couchman Jonathan | 10% Owner, See Footnote 1 | Buy | 950,623 | $0.24 | $230,186.61 | +25.5% | |
| Aug 14, 2018 | Couchman Jonathan | 10% Owner, See Footnote 1 | Buy | 998,402 | $0.26 | $258,605.92 | +27.9% |